160 related articles for article (PubMed ID: 21112752)
21. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
Yang SP; Raner GM
Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
[TBL] [Abstract][Full Text] [Related]
22. In vitro study of the inhibition and induction of human cytochromes P450 by crystalline glucosamine sulfate.
Persiani S; Canciani L; Larger P; Rotini R; Trisolino G; Antonioli D; Rovati LC
Drug Metabol Drug Interact; 2009; 24(2-4):195-209. PubMed ID: 20408500
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
Kim KA; Lee JS; Park HJ; Kim JW; Kim CJ; Shim IS; Kim NJ; Han SM; Lim S
Life Sci; 2004 Apr; 74(22):2769-79. PubMed ID: 15043991
[TBL] [Abstract][Full Text] [Related]
24. Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures.
Pekthong D; Blanchard N; Abadie C; Bonet A; Heyd B; Mantion G; Berthelot A; Richert L; Martin H
Chem Biol Interact; 2009 May; 179(2-3):247-55. PubMed ID: 19041297
[TBL] [Abstract][Full Text] [Related]
25. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
26. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of genipin on human cytochrome P450 isoenzymes and P-glycoprotein in vitro.
Gao LN; Zhang Y; Cui YL; Yan K
Fitoterapia; 2014 Oct; 98():130-6. PubMed ID: 25073096
[TBL] [Abstract][Full Text] [Related]
28. Modulatory actions of o-coumaric acid on carcinogen-activating cytochrome P450 isozymes and the potential for drug interactions in human hepatocarcinoma cells.
Sen A; Terzioglu G; Atmaca P; Celik G; Ozgun O; Arslan S
Pharm Biol; 2015; 53(9):1391-8. PubMed ID: 25880144
[TBL] [Abstract][Full Text] [Related]
29. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions.
Martey ON; He X; Xing H; Deng F; Feng S; Li C; Shi X
Biopharm Drug Dispos; 2014 May; 35(4):195-206. PubMed ID: 24424534
[TBL] [Abstract][Full Text] [Related]
30. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue.
Raunio H; Hakkola J; Hukkanen J; Lassila A; Päivärinta K; Pelkonen O; Anttila S; Piipari R; Boobis A; Edwards RJ
Exp Toxicol Pathol; 1999 Jul; 51(4-5):412-7. PubMed ID: 10445407
[TBL] [Abstract][Full Text] [Related]
31. Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line.
Xie HJ; Lundgren S; Broberg U; Finnström N; Rane A; Hassan M
Eur J Pharmacol; 2002 Aug; 449(3):197-205. PubMed ID: 12167460
[TBL] [Abstract][Full Text] [Related]
32. In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes.
Chen N; Cui D; Wang Q; Wen Z; Finkelman RD; Welty D
Xenobiotica; 2018 Jun; 48(6):637-646. PubMed ID: 28730856
[TBL] [Abstract][Full Text] [Related]
33. STAT5A and STAT5B have opposite correlations with drug response gene expression.
Lamba V; Jia B; Liang F
Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
[TBL] [Abstract][Full Text] [Related]
34. Effect of bixin and norbixin on the expression of cytochrome P450 in HepG2 cell line.
Matuo MC; de Oliveira Takamoto RT; Kikuchi IS; de Jesus Andreoli Pinto T
Cell Biol Int; 2013 Aug; 37(8):843-8. PubMed ID: 23554079
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.
Satoh D; Iwado S; Abe S; Kazuki K; Wakuri S; Oshimura M; Kazuki Y
PLoS One; 2017; 12(10):e0187072. PubMed ID: 29065189
[TBL] [Abstract][Full Text] [Related]
36. Interindividual variability in inhibition and induction of cytochrome P450 enzymes.
Lin JH; Lu AY
Annu Rev Pharmacol Toxicol; 2001; 41():535-67. PubMed ID: 11264468
[TBL] [Abstract][Full Text] [Related]
37. Application of mechanism-based CYP inhibition for predicting drug-drug interactions.
Zhou ZW; Zhou SF
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):579-605. PubMed ID: 19466877
[TBL] [Abstract][Full Text] [Related]
38. Thunbergia laurifolia extract minimizes the adverse effects of toxicants by regulating P-glycoprotein activity, CYP450, and lipid metabolism gene expression in HepG2 cells.
Rocejanasaroj A; Tencomnao T; Sangkitikomol W
Genet Mol Res; 2014 Jan; 13(1):205-19. PubMed ID: 24446304
[TBL] [Abstract][Full Text] [Related]
39. Modulation of CYPs, P-gp, and PXR by Eschscholzia californica (California Poppy) and Its Alkaloids.
Manda VK; Ibrahim MA; Dale OR; Kumarihamy M; Cutler SJ; Khan IA; Walker LA; Muhammad I; Khan SI
Planta Med; 2016 Apr; 82(6):551-8. PubMed ID: 27054913
[TBL] [Abstract][Full Text] [Related]
40. Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes.
Alonso S; Su M; Jones JW; Ganguly S; Kane MA; Jones RJ; Ghiaur G
Oncotarget; 2015 Jun; 6(17):14905-12. PubMed ID: 25915157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
